Predictive value of mid luteal progesterone concentration before luteal support in controlled ovarian hyperstimulation with intrauterine insemination. 2004

Michael F Costello, and Sandra Emerson, and Julie Lukic, and Peter Sjoblom, and Don Garrett, and Graeme Hughes, and Stephen Steigrad
Department of Reproductive Medicine and IVF Australia, Royal Hospital for Women, Randwick, Sydney, New South Wales, Australia. mfcostello@unsw.edu.au

BACKGROUND There is no published data assessing whether higher mid luteal serum progesterone (P4) levels are associated with a higher cycle pregnancy rate (CPR) in controlled ovarian hyperstimulation (COH) with intrauterine insemination (IUI). OBJECTIVE To assess whether the mid luteal serum P4 level is predictive of pregnancy in COH with IUI. METHODS A retrospective cohort study of all women with unexplained, minimal endometriosis or mild male factor infertility who underwent COH with IUI between October 1999 and December 2000 at our department was analysed. The COH was achieved with follicle stimulating hormone injections. All cycles were triggered with human chorionic gonadotropin when at least one follicle > or =15 mm was visible on ultrasound and IUI performed the following day. A serum P4 and beta human chorionic gonadotropin level was measured at 7 and 14 days post-trigger, respectively. RESULTS There were 33 pregnancies in the 188 cycles analysed, giving a CPR of 18%. The median (range) mid luteal P4 level for all cycles was 51 nmol/L (1.8-234). This did not differ between the pregnant (55 nmol/L) and non-pregnant (50 nmol/L) cycles (P=0.282, Mann-Whitney U-test). There was also no difference in CPR between cohorts below or above the cut-off levels of 33 nmol/L (25th percentile) (13.3 vs 18.9%; P=0.39), 51 nmol/L (50th percentile) (16.0 vs 19.1%; P=0.57), or 69 nmol/L (75th percentile) (16.3 vs 21.3%; P=0.44), respectively. CONCLUSIONS Increased mid luteal serum P4 levels are not associated with a higher CPR in women undergoing COH with IUI. However, a low mid luteal P4 level < or =25 nmol/L may help predict treatment failure.

UI MeSH Term Description Entries
D007247 Infertility, Female Diminished or absent ability of a female to achieve conception. Sterility, Female,Sterility, Postpartum,Sub-Fertility, Female,Subfertility, Female,Female Infertility,Female Sterility,Female Sub-Fertility,Female Subfertility,Postpartum Sterility,Sub Fertility, Female
D007315 Insemination, Artificial Artificial introduction of SEMEN or SPERMATOZOA into the VAGINA to facilitate FERTILIZATION. Artificial Insemination,Eutelegenesis,Artificial Inseminations,Eutelegeneses,Inseminations, Artificial
D008183 Luteal Phase The period in the MENSTRUAL CYCLE that follows OVULATION, characterized by the development of CORPUS LUTEUM, increase in PROGESTERONE production by the OVARY and secretion by the glandular epithelium of the ENDOMETRIUM. The luteal phase begins with ovulation and ends with the onset of MENSTRUATION. Menstrual Cycle, Luteal Phase,Menstrual Cycle, Secretory Phase,Menstrual Secretory Phase,Postovulatory Phase,Phase, Luteal,Phase, Postovulatory,Secretory Phase, Menstrual
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011336 Probability The study of chance processes or the relative frequency characterizing a chance process. Probabilities
D011374 Progesterone The major progestational steroid that is secreted primarily by the CORPUS LUTEUM and the PLACENTA. Progesterone acts on the UTERUS, the MAMMARY GLANDS and the BRAIN. It is required in EMBRYO IMPLANTATION; PREGNANCY maintenance, and the development of mammary tissue for MILK production. Progesterone, converted from PREGNENOLONE, also serves as an intermediate in the biosynthesis of GONADAL STEROID HORMONES and adrenal CORTICOSTEROIDS. Pregnenedione,Progesterone, (13 alpha,17 alpha)-(+-)-Isomer,Progesterone, (17 alpha)-Isomer,Progesterone, (9 beta,10 alpha)-Isomer
D005260 Female Females
D005300 Fertility Agents, Female Compounds which increase the capacity to conceive in females. Fertility Agents, Female, Hormonal,Fertility Agents, Female, Synthetic,Infertility Agents, Female,Female Fertility Agents, Synthetic,Infertility Drugs, Female,Synthetic Female Fertility Agents,Agents, Female Fertility,Agents, Female Infertility,Drugs, Female Infertility,Female Fertility Agents,Female Infertility Agents,Female Infertility Drugs
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Michael F Costello, and Sandra Emerson, and Julie Lukic, and Peter Sjoblom, and Don Garrett, and Graeme Hughes, and Stephen Steigrad
November 1989, Human reproduction (Oxford, England),
Michael F Costello, and Sandra Emerson, and Julie Lukic, and Peter Sjoblom, and Don Garrett, and Graeme Hughes, and Stephen Steigrad
October 2017, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology,
Michael F Costello, and Sandra Emerson, and Julie Lukic, and Peter Sjoblom, and Don Garrett, and Graeme Hughes, and Stephen Steigrad
June 2006, Fertility and sterility,
Michael F Costello, and Sandra Emerson, and Julie Lukic, and Peter Sjoblom, and Don Garrett, and Graeme Hughes, and Stephen Steigrad
December 2005, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP,
Michael F Costello, and Sandra Emerson, and Julie Lukic, and Peter Sjoblom, and Don Garrett, and Graeme Hughes, and Stephen Steigrad
March 2014, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology,
Michael F Costello, and Sandra Emerson, and Julie Lukic, and Peter Sjoblom, and Don Garrett, and Graeme Hughes, and Stephen Steigrad
October 1999, Fertility and sterility,
Michael F Costello, and Sandra Emerson, and Julie Lukic, and Peter Sjoblom, and Don Garrett, and Graeme Hughes, and Stephen Steigrad
February 2006, Fertility and sterility,
Michael F Costello, and Sandra Emerson, and Julie Lukic, and Peter Sjoblom, and Don Garrett, and Graeme Hughes, and Stephen Steigrad
July 2012, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology,
Michael F Costello, and Sandra Emerson, and Julie Lukic, and Peter Sjoblom, and Don Garrett, and Graeme Hughes, and Stephen Steigrad
March 1991, Fertility and sterility,
Michael F Costello, and Sandra Emerson, and Julie Lukic, and Peter Sjoblom, and Don Garrett, and Graeme Hughes, and Stephen Steigrad
January 2017, The Journal of reproductive medicine,
Copied contents to your clipboard!